PMFA
EDIT icon

Plante Moran Financial Advisors’s Editas Medicine EDIT Stock Holding History

Plante Moran Financial Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247 Hold
100
– – ﹤0.01% 697
2025
Q4 		$205 Hold
100
– – ﹤0.01% 785
2025
Q3 		$347 Hold
100
– – ﹤0.01% 748
2025
Q2 		$220 Hold
100
– – ﹤0.01% 750
2025
Q1 		$116 Hold
100
– – ﹤0.01% 776
2024
Q4 		$127 Hold
100
– – ﹤0.01% 888
2024
Q3 		$341 Hold
100
– – ﹤0.01% 843
2024
Q2 		$467 Hold
100
– – ﹤0.01% 745
2024
Q1 		$742 Buy
+100
New +$831 ﹤0.01% 795

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Plante Moran Financial Advisors's EDIT Position: Q1 2026 in Review

Plante Moran Financial Advisors held its Editas Medicine (EDIT) position steady in Q1 2026 at 100 shares worth $247. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Plante Moran Financial Advisors first reported a position in EDIT in Q1 2024 and has held it in 9 quarters since. The position peaked at $742 in Q1 2024. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Plante Moran Financial Advisors held 100 shares of Editas Medicine worth $247 as of Q1 2026.
  • Plante Moran Financial Advisors left its Editas Medicine share count unchanged in Q1 2026.
  • Editas Medicine made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q1 2026, its #697 holding.
  • Plante Moran Financial Advisors first reported a position in Editas Medicine in Q1 2024 and has held it in 9 quarters since.
  • Plante Moran Financial Advisors's Editas Medicine position peaked at $742 in Q1 2024.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.